CLINICAL COMPARISON OF FIRST-LINE PLATIN CHEMOTHERAPY REGIMENS IN PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) USING GERMAN REGISTRY DATA

被引：3
|
作者：
Haas, J. S. [1 ]
Meise, D. [1 ]
Ogbonnaya, A. [2 ]
Braun, S. [1 ]
Eaddy, M. [3 ]
Daessler, K. [4 ]
Sandner, R. [5 ]
Binninger, A. [6 ]
Jaenicke, M. [6 ]
Chiabudini, M. [6 ]
Marschner, N. [7 ]
机构：
[1] Xcenda GmbH, Hannover, Germany
[2] Xcenda LLC, Sci Consulting, Palm Harbor, FL USA
[3] Xcenda LLC, Palm Harbor, FL USA
[4] Onkol Schwerpunktpraxis, Freital, Germany
[5] Gemeinschaftspraxis Dr Prenninger & Dr Sandner, Passau, Germany
[6] iOMEDICO AG, Freiburg, Germany
[7] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.112
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN30
引用
收藏
页码：A416 / A417
页数：2
相关论文
共 50 条
  • [21] A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China
    Zheng, Zhiwei
    Zhu, Gaofeng
    Cao, Xueqiong
    Cai, Hongfu
    Zhu, Huide
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (03) : 267 - 273
  • [22] Quantitative comparison of the efficacies and safety profiles of three first-line non-platinum chemotherapy regimens for advanced non-small cell lung cancer
    Yang, Qian-Yu
    Zhu, Lin
    Liu, Hong-Xia
    Zheng, Qing-Shan
    Li, Lu-Jin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] First-line cisplatin plus pemetrexed therapy for selected patients with advanced nonsquamous non-small cell lung cancer.
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Imai, Hisao
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Endo, Masahiro
    Takahashi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Changes in global patterns of care for first-line advanced nonsquamous (NS) non-small cell lung cancer (NSCLC): 2007-2010
    Combest, A. J.
    Bryan, J. K.
    Moseley, A.
    Reitsma, D. J.
    Scazafave, M.
    Wood, J. M.
    Iocca, H. A.
    Goyo, J.
    An, J. S.
    Lee, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer
    Garcia-Fumero, Ricardo
    Fernandez-Lopez, Cristina
    Calleja-Hernandez, Miguel angel
    Exposito-Ruiz, Manuela
    Espin, Jaime
    Exposito-Hernandez, Jose
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (10): : 433 - 438
  • [26] EFFICACY AND SAFETY OF CISPLATIN/PEMETREXED AS FIRST-LINE TREATMENT FOR JAPANESE PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Yamaguchi, Teppei
    Nakanishi, Toru
    Hayashi, Masamichi
    Isogai, Sumito
    Hoshino, Tami
    Mieno, Yuki
    Uozu, Sakurako
    Morishita, Mariko
    Okamura, Takuya
    Takeyama, Tomoko
    Minezawa, Tomoyuki
    Morikawa, Sayako
    Niwa, Yoshikazu
    Okazawa, Mitsushi
    Imaizumi, Kazuyoshi
    RESPIROLOGY, 2013, 18 : 83 - 83
  • [27] Characteristics, Treatment Patterns, and Costs of First-line Treatment Regimens for Advanced Nonsquamous Non-small Cell Lung Cancer (nsq NSCLC) Treated by Medical Oncologists in Outpatient Settings
    Shah, M.
    Winfree, K. B.
    Peterson, P.
    Gruschkus, S. K.
    Eaddy, M. T.
    Green, M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S241 - S241
  • [28] Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015
    Toshiyuki Kozuki
    Naoyuki Nogami
    Hiromoto Kitajima
    Shunichiro Iwasawa
    Emiko Sakaida
    Yuichi Takiguchi
    Satoshi Ikeda
    Masahiro Yoshida
    Terufumi Kato
    Shingo Miyamoto
    Kentaro Sakamaki
    Tetsu Shinkai
    Koshiro Watanabe
    BMC Cancer, 16
  • [29] Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015
    Kozuki, Toshiyuki
    Nogami, Naoyuki
    Kitajima, Hiromoto
    Iwasawa, Shunichiro
    Sakaida, Emiko
    Takiguchi, Yuichi
    Ikeda, Satoshi
    Yoshida, Masahiro
    Kato, Terufumi
    Miyamoto, Shingo
    Sakamaki, Kentaro
    Shinkai, Tetsu
    Watanabe, Koshiro
    BMC CANCER, 2016, 16
  • [30] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
12345